EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
151 hedge funds and large institutions have $659M invested in Eagle Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 62 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+5
Holders Change %
+3.42%
% of All Funds
2.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
15
Increased
43
Reduced
62
Closed
9
Calls
$1.63M
Puts
–
Net Calls
+$1.63M
Net Calls Change
+$1.63M
Top Buyers
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
$3.89M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
$7.21M |
| 3 |
Goldman Sachs
New York
|
$5.97M |
| 4 |
Millennium Management
New York
|
$767K |
| 5 |
BIP
Brandes Investment Partners
La Jolla,
California
|
$37.5M |
